Personalis logo

Personalis Share Price Today

(NASDAQ: PSNL)

Personalis share price is $3.19 & ₹272.63 as on 18 Apr 2025, 2.30 'hrs' IST

$3.19

-0.1

(-3.04%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Personalis share price in Dollar and Rupees. Guide to invest in Personalis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Personalis, along with analyst recommendations, forecasts, and comprehensive financials.

Personalis share price movements

  • Today's Low: $3.10
    Today's High: $3.33

    Day's Volatility :6.87%

  • 52 Weeks Low: $1.14
    52 Weeks High: $7.20

    52 Weeks Volatility :84.24%

Personalis (PSNL) Returns

PeriodPersonalis IncSector (Health Care)Index (Russel 2000)
3 Months
-42.52%
-2.8%
0.0%
6 Months
-33.12%
-11.0%
0.0%
1 Year
147.29%
-1.9%
0.0%
3 Years
-47.53%
-1.5%
-12.9%

Personalis (PSNL) Key Statistics

in dollars & INR

Previous Close
$3.29
Open
$3.3
Today's High
$3.3286
Today's Low
$3.1
Market Capitalization
$281.7M
Today's Volume
$695.2K
52 Week High
$7.2
52 Week Low
$1.135
Revenue TTM
$84.6M
EBITDA
$-57.3M
Earnings Per Share (EPS)
$-1.37
Profit Margin
-96.06%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-48.91%

How to invest in Personalis Stock (PSNL) from India?

It is very easy for Indian residents to invest directly in Personalis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Personalis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Personalis or PSNL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Personalis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Personalis shares which would translate to 0.268 fractional shares of Personalis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Personalis, in just a few clicks!

Returns in Personalis (PSNL) for Indian investors in Rupees

The Personalis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Personalis investment value today

Current value as on today

₹2,49,628

Returns

₹1,49,628

(+149.63%)

Returns from Personalis Stock

₹1,47,287 (+147.29%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Personalis (PSNL)

-32%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Personalis Stock from India on INDmoney has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Personalis

  • Merck & Co Inc

    15.90%

  • Lightspeed Management Co LLC

    9.24%

  • ARK Investment Management LLC

    7.67%

  • AIGH Capital Management, LLC

    4.30%

  • BlackRock Inc

    3.35%

  • Vanguard Group Inc

    1.96%

Analyst Recommendation on Personalis

Rating
Trend

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Personalis(by analysts ranked 0 to 5 stars)

Analyst Forecast on Personalis Stock (PSNL)

What analysts predicted

Upside of 129.88%

Target:

$7.33

Current:

$3.19

Insights on Personalis Stock (Ticker Symbol: PSNL)

  • Price Movement

    In the last 1 year, PSNL stock has moved up by 155.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 25.70M → 16.8M (in $), with an average decrease of 34.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -39.08M → -16.42M (in $), with an average increase of 138.0% per quarter
  • PSNL vs A (3 yr)

    In the last 3 years, Personalis Inc has experienced a drawdown of -51.6%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 31.9%

PSNL Personalis Financials in INR & Dollars

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$84.6M
↑ 15.15%
Net Income
$-81.3M
↓ 24.94%
Net Profit Margin
-96.06%
↑ 51.32%

Personalis Technicals Summary

Sell

Neutral

Buy

Personalis is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Personalis (PSNL) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Personalis Inc logo
-8.86%
-33.12%
147.29%
-47.53%
-63.95%
Agilent Technologies Inc. logo
-14.62%
-25.07%
-22.79%
-20.79%
32.45%
Idexx Laboratories, Inc. logo
-4.34%
-9.24%
-13.62%
-19.85%
53.92%
Thermo Fisher Scientific, Inc. logo
-15.78%
-28.2%
-21.53%
-27.68%
30.67%
Danaher Corp. logo
-9.32%
-31.34%
-20.67%
-33.37%
19.89%
Iqvia Holdings Inc. logo
-19.44%
-37.75%
-36.91%
-40.72%
12.86%

About Personalis

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for the detection of MRD; and NeXT Dx, a tumor profiling test that is used to help select therapy for a cancer patient and identify potential clinical trials for a patient. In addition, the company performs whole exome sequencing of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing on human samples for research projects, such as population sequencing initiatives. Its services are used by pharmaceutical companies for translational research, biomarker discovery, the development of personalized cancer therapies, and for clinical trials, as well as tests are used by physicians to detect residual or recurrent cancer in patients, monitor cancer response to therapy, and uncover insights for therapy selection. The company's customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. Personalis, Inc. was incorporated in 2011 and is headquartered in Fremont, California.
Organization
Personalis
Employees
228
CEO
Mr. Christopher M. Hall
Industry
Biotechnology

Management People of Personalis

NameTitle
Mr. Christopher M. Hall
President, CEO & Director
Mr. Aaron L. Tachibana
CFO & COO
Dr. Richard Chen M.D., M.S.
Executive VP of R&D and Chief Medical Officer
Dr. Russ B. Altman M.D., Ph.D.
Co-Founder and Member of Clinical & Scientific Advisory Board
Dr. Euan Angus Ashley DPHIL, FRCP, M.D., Ph.D.
Co-Founder and Member of Clinical & Scientific Advisory Board
Dr. Michael P. Snyder Ph.D.
Co-Founder and Member of Clinical & Scientific Advisory Board
Mr. Stephen M. Moore J.D.
Senior VP, Chief Legal Officer & Corporate Secretary
Dr. Christian Haudenschild Ph.D.
Senior Vice President of Genomic Laboratory Operations
Mr. Stephane Mouradian Ph.D.
Senior Vice President of Business Development
Ms. Deepshikha Bhandari
Senior Vice President of Regulatory, Quality & Clinical Compliance

Important FAQs about investing in PSNL Stock from India :

What is Personalis share price today?

Personalis share price today stands at $3.19, Open: $3.30 ; Previous Close: $3.29 ; High: $3.33 ; Low: $3.10 ; 52 Week High: $7.20 ; 52 Week Low: $1.14.

The stock opens at $3.30, after a previous close of $3.29. The stock reached a daily high of $3.33 and a low of $3.10, with a 52-week high of $7.20 and a 52-week low of $1.14.

Can Indians buy Personalis shares?

Yes, Indians can invest in the Personalis (PSNL) from India.

With INDmoney, you can buy Personalis at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Personalis at zero transaction cost.

How can I buy Personalis shares from India?

It is very easy to buy Personalis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Personalis (PSNL) be purchased?

Yes, you can buy fractional shares of Personalis with INDmoney app.

What are the documents required to start investing in Personalis stocks?

To start investing in Personalis, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Personalis Stock (PSNL)?

Today’s highest price of Personalis (PSNL) is $3.33.

Today’s lowest price of Personalis (PSNL) is $3.10.

What is today's market capitalisation of Personalis?

Today's market capitalisation of Personalis PSNL is 281.7M

What is the 52 Week High and Low Range of Personalis Stock (PSNL)?

  • 52 Week High

    $7.20

  • 52 Week Low

    $1.14

What are the historical returns of Personalis (PSNL)?

  • 1 Month Returns

    -8.86%

  • 3 Months Returns

    -33.12%

  • 1 Year Returns

    147.29%

  • 5 Years Returns

    -63.95%

Who is the Chief Executive Officer (CEO) of Personalis ?

Mr. Christopher M. Hall is the current Chief Executive Officer (CEO) of Personalis.